Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-207

I went on to clarify what I meant a little further down.

And congrats on college. Then you should know patients are much more heterogenous than coins, and there is a legitimate need for larger trials and controls despite initially promising results.

I'm glad your so confident on the trials success. I need more evidence before I make that bold of a claim. So do the doctors who will use the product, the hospitals that will purchase it, the FDA who may approve it and Novartis who has put conditions on their support for trial success.

Maybe they haven't quite grasped the concept of a coin flip, you should probably enlighten them